Ravi Agrawal, a promoter of Ajanta Pharma Limited, has released a pledge on 1,30,000 shares, equivalent to 0.10% of the total share capital. The release occurred on September 5, 2025, and was attributed to re-financing.
The shares, previously encumbered under Ravi Agrawal Trust, now result in 5,877,642 encumbered shares, representing 4.70% of the total share capital.
Barclays Investment and Loans (India) Private Limited acted as the lender, while Barclays Securities (India) Private Limited served as the DP.
| Promoter Name | Total Shares | Shares Encumbered Before | % of Total Share Capital Before | Shares Released | Shares Encumbered After | % of Total Share Capital After |
|---|---|---|---|---|---|---|
| Ravi P Agrawal, trustee Ravi Agrawal Trust | 16,242,904 | 6,007,642 | 4.81% | 130,000 | 5,877,642 | 4.70% |
| Aayush M Agrawal, trustee Aayush Agrawal Trust | 14,112,924 | 5,935,002 | 4.75% | 0 | 5,935,002 | 4.75% |
Other promoters with encumbered shares include Yogesh M Agrawal, trustee Yogesh Agrawal Trust with 18,078,147 shares (14.47%), and Rajesh M Agrawal, trustee Rajesh Agrawal Trust with 18,078,148 shares (14.47%). Gabs Investments Pvt Ltd holds 12,588,393 shares (10.08%).
Following the release of 1,30,000 shares, the encumbered shares under Ravi P Agrawal, trustee Ravi Agrawal Trust, now total 5,877,642, representing 4.70% of the total share capital.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
